A mathematical model of tumor-immune interactions

被引:119
|
作者
Robertson-Tessi, Mark [1 ]
El-Kareh, Ardith [2 ]
Goriely, Alain [3 ]
机构
[1] Univ Arizona, Program Appl Math, Tucson, AZ 85721 USA
[2] Univ Arizona, ARL Microcirculat Div, Tucson, AZ 85724 USA
[3] Oxford Ctr Collaborat Appl Math, Math Inst, Oxford OX2 6HA, England
基金
美国国家科学基金会;
关键词
Immunosuppression; Regulatory T cells; TGF-beta; IL-10; Tumor growth; REGULATORY T-CELLS; DENDRITIC CELLS; TGF-BETA; BREAST-CANCER; IN-VIVO; INDUCED IMMUNOSUPPRESSION; COLORECTAL-CARCINOMA; PERIPHERAL-BLOOD; HALF-LIFE; GROWTH;
D O I
10.1016/j.jtbi.2011.10.027
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
A mathematical model of the interactions between a growing tumor and the immune system is presented. The equations and parameters of the model are based on experimental and clinical results from published studies. The model includes the primary cell populations involved in effector T-cell mediated tumor killing: regulatory T cells, helper T cells, and dendritic cells. A key feature is the inclusion of multiple mechanisms of immunosuppression through the main cytokines and growth factors mediating the interactions between the cell populations. Decreased access of effector cells to the tumor interior with increasing tumor size is accounted for. The model is applied to tumors with different growth rates and antigenicities to gauge the relative importance of various immunosuppressive mechanisms. The most important factors leading to tumor escape are TGF-beta-induced immunosuppression, conversion of helper T cells into regulatory T cells, and the limitation of immune cell access to the full tumor at large tumor sizes. The results suggest that for a given tumor growth rate, there is an optimal antigenicity maximizing the response of the immune system. Further increases in antigenicity result in increased immunosuppression, and therefore a decrease in tumor killing rate. This result may have implications for immunotherapies which modulate the effective antigenicity. Simulation of dendritic cell therapy with the model suggests that for some tumors, there is an optimal dose of transfused dendritic cells. (C) 2011 Elsevier Ltd. All rights reserved,
引用
收藏
页码:56 / 73
页数:18
相关论文
共 50 条
  • [21] A mathematical model for tumor-immune competitive system with multiple time delays
    Sardar, Mrinmoy
    Khajanchi, Subhas
    Biswas, Santosh
    Ghosh, Sumana
    [J]. CHAOS SOLITONS & FRACTALS, 2024, 179
  • [22] On a Mathematical Model of Tumor-Immune Interaction with a Piecewise Differential and Integral Operator
    Rezapour, Shahram
    Deressa, Chernet Tuge
    Mukharlyamov, Robert G.
    Etemad, Sina
    [J]. JOURNAL OF MATHEMATICS, 2022, 2022
  • [23] Laser immunotherapy and the tumor-immune system interaction: a mathematical model and analysis
    Laverty, Sean M.
    Dawkins, Bryan A.
    Chen, Wei R.
    [J]. BIOPHOTONICS AND IMMUNE RESPONSES IX, 2014, 8944
  • [24] A model for tumor-immune interaction
    de Souza, Natalie
    [J]. NATURE METHODS, 2018, 15 (10) : 762 - 762
  • [25] Mathematical Modelling for the Role of CD4+T Cells in Tumor-Immune Interactions
    Makhlouf, Ahmed M.
    El-Shennawy, Lamiaa
    Elkaranshawy, Hesham A.
    [J]. COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2020, 2020
  • [26] Bistability in a model of tumor-immune system interactions with an oncolytic viral therapy
    Vithanage, G. V. R. K.
    Wei, Hsiu-Chuan
    Jang, Sophia R-J
    [J]. MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2022, 19 (02) : 1559 - 1587
  • [27] Analysis of tumor-immune functional responses in a mathematical model of neoantigen cancer vaccines
    Han, Lifeng
    Messan, Marisabel Rodriguez
    Yogurtcu, Osman N.
    Nukala, Ujwani
    Yang, Hong
    [J]. MATHEMATICAL BIOSCIENCES, 2023, 356
  • [28] Tumor-Immune Interaction, Surgical Treatment, and Cancer Recurrence in a Mathematical Model of Melanoma
    Eikenberry, Steffen
    Thalhauser, Craig
    Kuang, Yang
    [J]. PLOS COMPUTATIONAL BIOLOGY, 2009, 5 (04)
  • [29] Stability analysis of fractional order mathematical model of tumor-immune system interaction
    Ozturk, Ilhan
    Ozkose, Fatma
    [J]. CHAOS SOLITONS & FRACTALS, 2020, 133 (133)
  • [30] Tumor-Immune interactions: implications for cancer therapy
    Tham, Muly
    Abastado, Jean-Pierre
    [J]. CELL CYCLE, 2015, 14 (09) : 1347 - 1348